Skip to main content
Daily market wrap · Monday, 13 July 2026
~2 min read

Nifty flat, IT surges — tape still range-bound

The index went nowhere but the internals tell a muddier story than the headline suggests.
Stage2Stocks Market Desk
Nifty 50
24,211
+0% on the day
Regime
Bull rising
29th day · neutral-to-up
Breadth
45%
above 200-DMA · narrow
Adv / Dec
1,136 / 1,081
advancers ahead
52w highs / lows
205 / 62
net +143
Stage-2 share
35%
cohort widening

The tape is range-bound and the trajectory is mixed — this is not a dip inside a clean uptrend, nor is it the start of a decisive top, but it is not a green light either. Nifty 50 closed at 24,211, flat on the day and still below its 200-day average, sitting 8% off its 52-week high. The structural backdrop is slowly rebuilding, but the short-term internals are choppy enough that setups clearing the screen today deserve more scepticism than usual.

Trajectory: recovering from a sharp dip, but no conviction yet

The continuity series tells the story plainly. The 8th July saw a -2.1% index drop, the fast short-term breadth (the share of stocks above their 20-day average) collapsed to 34.9% and net new highs flipped negative. The two sessions since have clawed back — the fast gauge recovered to 52.2% today and net new highs reached 143 — but today's advance-decline was barely positive at 1,136 to 1,081, and the index itself printed zero. The slow structural gauge, the share of stocks above their 200-day average, has edged back to 44.9% after dipping to 39.1% on the 8th, which is a stabilising signal, not a strong one. The Stage-2 cohort is widening over 20 and 60 days, and the 5-day transition flow is net positive at 41 stocks moving Stage 1 to 2 against 31 going the other way — but with the index below its 200-day average and the fast breadth still only mid-range, follow-through on any individual setup is a lower-probability proposition than the raw setup count implies.

Leadership: IT had the day, Health Care and Consumer Discretionary have the trend

Information Technology led on the day with a 3% gain — notable given it is a 3-month laggard at -0.6%, so treat that as a single-session bounce until proven otherwise. The durable leadership over one and three months sits in Real Estate, Financials, and Health Care. Health Care and Consumer Discretionary are where the Stage-2 cohort is expanding fastest over the last 20 days, with Financials close behind — those three sectors are where the screen is finding the most consistent Stage-2 setups. Bharat Seats and Tirupati Forge from Consumer Discretionary, and Fusion Finance from Financials, are among the names that have cleared the screen with the cleanest base scores, but in a range-bound tape with the index below its 200-day average, the bar for a setup to follow through is higher than the scores alone suggest.

Leading Stage-2 setups
StockSectorSetup% 1D
Aurum Proptech LtdInformation Technology9.4
Fusion Finance LtdFinancials9.4
Lokesh Machines LtdIndustrials9.4
Bharat Seats LtdConsumer Discretionary9.4
Tirupati Forge LtdConsumer Discretionary9.4
Knowledge Marine & Engineering Works LtdIndustrials9.0
Macpower CNC Machines LtdIndustrials9.0
Venus Pipes and Tubes LtdMaterials9.0
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Information Technology+3.0%+5.5%-0.6%3728%
Consumer Discretionary+0.3%+8.4%+8.5%6635%
Financials+0.1%+8.6%+4.3%6135%
Health Care-0.0%+6.7%+19.7%7351%
Real Estate-0.0%+22.7%+25.2%5422%
Utilities-0.1%+2.7%+16.4%6328%
Industrials-0.2%+6.4%+19.5%6838%
Energy-0.2%+3.8%-0.2%5339%
Materials-0.5%+2.2%+6.8%6637%
Communication Services-0.6%+8.8%+13.5%6018%
Consumer Staples-0.8%+1.7%+6.0%5533%
Breadth note
205 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps